| Lactate metabolism in human lung tumors B Faubert, KY Li, L Cai, CT Hensley, J Kim, LG Zacharias, C Yang, QN Do, ... Cell 171 (2), 358-371. e9, 2017 | 1196 | 2017 |
| Metabolic Heterogeneity in Human Lung Tumors Cell 164 (4), 681–694, 2016 | 1047 | 2016 |
| Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport C Yang, B Ko, CT Hensley, L Jiang, AT Wasti, J Kim, J Sudderth, ... Molecular cell 56 (3), 414-424, 2014 | 709 | 2014 |
| Amino acids in cancer EL Lieu, T Nguyen, S Rhyne, J Kim Experimental & molecular medicine 52 (1), 15-30, 2020 | 706 | 2020 |
| Mechanisms and implications of metabolic heterogeneity in cancer J Kim, RJ DeBerardinis Cell metabolism 30 (3), 434-446, 2019 | 496 | 2019 |
| CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells J Kim, Z Hu, L Cai, K Li, E Choi, B Faubert, D Bezwada, ... Nature 546 (7656), 168-172, 2017 | 292 | 2017 |
| Metabolic regulation of transcription through compartmentalized NAD+ biosynthesis WLK Keun Woo Ryu, Tulip Nandu, Jiyeon Kim, Sridevi Challa, Ralph J. DeBerardinis Science 360 (6389), eaan5780, 2018 | 239 | 2018 |
| RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors WJ Kim, EJ Kim, P Jeong, C Quan, J Kim, QL Li, JO Yang, Y Ito, SC Bae Cancer research 65 (20), 9347-9354, 2005 | 218 | 2005 |
| Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer HS Kim, S Mendiratta, J Kim, CV Pecot, JE Larsen, I Zubovych, BY Seo, ... Cell 155 (3), 552-566, 2013 | 200 | 2013 |
| Inosine monophosphate dehydrogenase dependence in a subset of small cell lung cancers F Huang, M Ni, MD Chalishazar, KE Huffman, J Kim, L Cai, X Shi, F Cai, ... Cell metabolism 28 (3), 369-382. e5, 2018 | 186 | 2018 |
| Metabolic diversity in human non-small cell lung cancer cells PH Chen, L Cai, K Huffman, C Yang, J Kim, B Faubert, L Boroughs, B Ko, ... Molecular cell 76 (5), 838-851. e5, 2019 | 171 | 2019 |
| Genotypes of TNF-α, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer EJ Kim, P Jeong, C Quan, J Kim, SC Bae, SJ Yoon, JW Kang, SC Lee, ... Urology 65 (1), 70-75, 2005 | 147 | 2005 |
| The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer J Kim, HM Lee, F Cai, B Ko, C Yang, EL Lieu, N Muhammad, S Rhyne, ... Nature metabolism 2 (12), 1401-1412, 2020 | 106 | 2020 |
| A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53 M Kurokawa, J Kim, J Geradts, K Matsuura, L Liu, X Ran, W Xia, TJ Ribar, ... Science signaling 6 (274), ra32-ra32, 2013 | 86 | 2013 |
| Rsk‐mediated phosphorylation and 14‐3‐3ε binding of Apaf‐1 suppresses cytochrome c‐induced apoptosis J Kim, AB Parrish, M Kurokawa, K Matsuura, CD Freel, JL Andersen, ... The EMBO journal 31 (5), 1279-1292, 2012 | 70 | 2012 |
| Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination XZ Chi, J Kim, YH Lee, JW Lee, KS Lee, H Wee, WJ Kim, WY Park, BC Oh, ... Cancer research 69 (20), 8111-8119, 2009 | 69 | 2009 |
| A century of the Warburg effect CB Thompson, KH Vousden, RS Johnson, WH Koppenol, H Sies, Z Lu, ... Nature Metabolism 5 (11), 1840-1843, 2023 | 47 | 2023 |
| Oncology therapeutics targeting the metabolism of amino acids N Muhammad, HM Lee, J Kim Cells 9 (8), 1904, 2020 | 41 | 2020 |
| RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation JH Kim, JW Jang, YS Lee, JW Lee, XZ Chi, YH Li, MK Kim, DM Kim, ... Oncogenesis 3 (4), e101-e101, 2014 | 34 | 2014 |
| Identification of RUNX3 as a component of the MST/Hpo signaling pathway B Min, MK Kim, JW Zhang, J Kim, KC Chung, BC Oh, GS Stein, YH Lee, ... Journal of cellular physiology 227 (2), 839-849, 2012 | 32 | 2012 |
